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Prmt5, an arginine methyltransferase, has multiple roles
in germ cells, and possibly in pluripotency. Here we
show that loss of Prmt5 function is early embryonic-le-
thal due to the abrogation of pluripotent cells in blasto-
cysts. Prmt5 is also up-regulated in the cytoplasm during
the derivation of embryonic stem (ES) cells together with
Stat3, where they persist to maintain pluripotency.
Prmt5 in association with Mep50 methylates cytosolic
histone H2A (H2AR3me2s) to repress differentiation
genes in ES cells. Loss of Prmt5 or Mep50 results in de-
repression of differentiation genes, indicating the signif-
icance of the Prmt5/Mep50 complex for pluripotency,
which may occur in conjunction with the leukemia in-
hibitory factor (LIF)/Stat3 pathway.
Supplemental material is available for this article.
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Prmt5, an arginine methyltransferase, has multiple cyto-
plasmic and nuclear substrates, including histone H2A/
H4 (H2A/H4R3me2s) (Bedford and Clarke 2009). We
showed previously that Prmt5 has a role in the establish-
ment and propagation of unipotent primordial germ cells
(PGCs) from embryonic day 7.5 (E7.5) to E11.5, where it
cooperates with Blimp1/Prdm1 (Ancelin et al. 2006), a
key regulator of PGC specification. During reprogram-
ming of E8.5 unipotent PGCs back to pluripotent embry-
onic germ (EG) cells in vitro, Blimp1/Prdm1 is rapidly
down-regulated, but Prmt5 translocates to the cytoplasm,
where it persists thereafter, suggesting that cytosolic
Prmt5 might have another distinct role in pluripotency
(Durcova-Hills et al. 2008). Indeed, cytosolic Prmt5 is also
detected in embryonic stem (ES) cells derived from blas-
tocysts (see later).
Pluripotency is established during preimplantation de-
velopment, where a number of factors, including epige-
netic regulators, play a critical role (Surani et al. 2007).
Pluripotent cells are established in the inner cell mass
(ICM) of blastocyst at E3.5, together with the outer
trophectoderm (TE) cells. The pluripotent cells can be
propagated indefinitely in vitro, which requires an in-
terplay between transcription factors, epigenetic regula-
tors, and signal transduction pathways, which ensures
repression of differentiation (Niwa 2007).
Here we investigate the role of Prmt5 in mouse de-
velopment, when pluripotent cells are established and
can be propagated as ES cells. Prmt5 is essential for early
development and, as a cytosolic factor, it is important for
the derivation and maintenance of pluripotent ES cells,
partly in association with Mep50, to direct methylation
of predeposited histone H2A.
Results and Discussion
Dynamic expression of Prmt5 in early embryos
and during ES cell derivation
First, we found that Prmt5 is maternally inherited in the
oocyte cytoplasm and is excluded from the metaphase
chromosomes. It remained cytoplasmic in the zygote and
was excluded from the pronuclei (PN) (Fig. 1A). During
the eight-cell to 16-cell transition, where totipotency is
lost, Prmt5 translocated into the nucleus; this event
coincides with the initiation of the first cell fate decision
toward the establishment of the outer TE and the ICM,
which contains the founder pluripotent cells (Fig. 1A). In
E3.5 blastocysts, Prmt5 is nuclear in both the inner and
outer cells, and, at E4.5, it persists in the nuclei of
differentiated TE cells but is down-regulated transiently
in the pluripotent ICM epiblast cells. At E6.5, we again
detected Prmt5 in the pluripotent epiblast cells of the
post-implantation embryo, but predominantly in the cy-
toplasm (Fig. 1A). These observations indicate the dy-
namic nature of Prmt5 localization in the nucleus and
cytoplasm in early development.
The transient loss of Prmt5 in the ICM epiblast is
noteworthy considering that there are high levels of
Prmt5 in ES cells. We therefore investigated E3.5 blasto-
cysts cultured in the presence of the cytokine leukemia
inhibitory factor (LIF) and fetal calf serum (FCS) to induce
ICM outgrowths from which ES cells are derived. We
found transient loss of Prmt5 in the epiblast over 24-h
culture (Fig. 1B), but it reappeared predominantly in the
cytoplasm of all ICM outgrowth cells, including Oct4-
positive pluripotent cells (Fig. 1B), which is reminiscent
of cytosolic expression in the E6.5 post-implantation
epiblast. Therefore, the re-expression of Prmt5 may be
coupled with development and proliferation of the epi-
blast in vivo and in vitro. Notably, the down-regulation of
Prmt5 in the epiblast cells must have occurred by a post-
transcriptional mechanism, since Prmt5 transcription per-
sists throughout this period (Fig. 1C). However, the un-
derlying mechanism is currently unknown. This regulated
and precipitant loss of predominantly nuclear-localized
Prmt5, and its subsequent reappearance in the cytoplasm,
signify an important developmental transition, which is
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reminiscent of the translocation of Prmt5 from the nucleus
to cytoplasm during reprogramming of unipotent PGCs to
pluripotent EG cells in vitro (Durcova-Hills et al. 2008).
Prmt5 is required for embryonic development
and the derivation of ES cells
Next, we asked if the early expression of Prmt5 is
essential for the development and derivation of ES cells,
using mutant mice generated from Prmt5+/ ES cells
containing a gene trap vector inserted between exons 6
and 7 that disrupts most of the methyltransferase domain
(Supplemental Fig. 1). Whereas Prmt5+/ mice were nor-
mal and fertile, we found no viable homozygous offspring
(Supplemental Table 1), and, furthermore, we confirmed
early embryonic lethality, where mutant embryos lacked
discernable embryonic structures at E6.5 (Supplemental
Fig. 1).
Next, we examined Prmt5/ E3.5 mutant blastocysts,
which we recovered at a normal Mendelian ratio, and
which weremorphologically indistinguishable fromwild-
type embryos (Supplemental Fig. 1). Mutant blastocysts
cultured in vitro in the context of ES cell derivation
hatched from the zona pellucida and attached, resulting
in the formation of trophoblast giant cells, but the ICM
failed to grow (Fig. 2A). Notably, no Prmt5-null ES cells
could be obtained, indicating that the up-regulation and
translocation of Prmt5 to the cytoplasm is as critical for
the derivation of ES cells as it is for embryonic develop-
ment in vivo.
Prmt5 is cytoplasmic in ES cells and essential
for pluripotency
We found that Prmt5 is highly expressed in ES cells and is
present almost exclusively in the cytoplasm (Fig. 2B),
which further strengthens the association between cyto-
solic Prmt5 and pluripotency. In contrast, Prmt5 is present
in the nucleus of TE stem cells in vitro (Fig. 2B)—which are
developmentally restricted to forming the extraembryonic
tissues only—and in differentiating ES cells that are
Oct4-negative (Fig. 2B). This suggests that the differential
nuclear or cytoplasmic localization may reflect diverse
roles of Prmt5 in pluripotency and cell fate determination.
Next, we used RNAi to deplete Prmt5 in ES cells,
which led to pronounced morphological changes and
loss of alkaline phosphatase staining, indicating a loss
of pluripotency (Fig. 3A). Notably, loss of Prmt5 also
resulted in down-regulation of key pluripotency genes,
including Oct4, Nanog, and Rex1, together with a re-
duction in Oct4 and Nanog proteins (Fig. 3A). Concom-
itantly, we detected up-regulation of several differentia-
tion genes, including Fgf5, Gata4, Gata6, and HoxD9, as
shown by quantitative PCR (qPCR) (Fig. 3B). Further-
more, global gene expression analysis following Prmt5
knockdown confirmed that numerous other ES-associ-
ated genes were significantly down-regulated, while de-
velopmentally regulated genes were up-regulated (Fig.
3C; Supplemental Table 2). Gene ontology (GO) analysis
confirmed down-regulation of ‘‘stem cell maintenance’’
genes, and up-regulation of ‘‘embryonic development’’
genes (Supplemental Table 2), which demonstrates that
cytoplasmic Prmt5 is crucial for the maintenance of
pluripotency in ES cells. We pursued this further for
mechanistic insights on the role of Prmt5 in ES cells.
Predeposited histone H2A is a substrate of cytoplasmic
Prmt5 in ES cells
Epigenetic regulators play a significant role in the re-
pression of differentiation genes in ES cells (Boyer et al.
Figure 1. Dynamic expression of Prmt5 in early embryos and ES
cell derivation. (A) Expression of Prmt5 (red) at various stages of
early development. Oct4-positive cells as well as Blimp1-GFP-
positive founder PGCs in E6.5 epiblasts are denoted in green. Nuclei
were counterstained with DAPI (blue). (EPI) Epiblast; (pTE) polar TE;
(mTE) mural TE. Bar, 20 mm. (B) Prmt5 (red) is up-regulated in the
ICM outgrowth during ES cell derivation in vitro. Oct4 (green)
marks pluripotent cells. (TGC) Trophoblast giant cells. (C) Prmt5
mRNA expression remains unchanged in Oct4-positive cells in the
course of ES derivation, based on single-cell RNA-Seq analysis (Tang
et al. 2010).
Figure 2. Effects of Prmt5 loss of function and detection of
cytoplasmic Prmt5 in ES cells. (A) A representative display of six
blastocyst outgrowths (OG) from a Prmt5+/ intercross. Outgrowths
4–6 showed impaired ICM proliferation, and were verified as
Prmt5/ by qPCR. Levels of Prmt5 transcript were normalized
against Gapdh, and results are shown on a log2 scale. Bar, 20 mm. (B)
Immunostainings of Prmt5 (red) in pluripotent ES, TS, and differen-
tiated ES cells. Oct4 and Cdx2 are in green. Nuclei were counter-
stained with DAPI (blue). (Right panel) Western blot of cytoplasmic
and nuclear fractions from ES cells confirms cytoplasmic location of
Prmt5. Purity of the preparations was confirmed by Oct4 (nuclear)
and Tubulin (cytoplasmic) expression. Bar, 20 mm.
Cytoplasmic Prmt5 and ES cell pluripotency
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2006; Bilodeau et al. 2009; Yeap et al. 2009; Yuan et al. 2009),
usually in the context of chromatin. Prmt5 can methylate
histones H2A/H4 to generate H2AR3me2s/H4R3me2s
modifications that are associated with gene repression
(Pollack et al. 1999; Ancelin et al. 2006). However, since
Prmt5 is cytoplasmic in ES cells, we first checked for enzy-
matic activity toward histones. We found that Prmt5 im-
munoprecipitated from ES cells could methylate histones
H2A and H4 in vitro (Fig. 4A). We then asked if cytoplasmic
Prmt5 in ES cells in vivo has a role in histone methylation,
by investigating the levels of H2AR3me2s- and H4R3me2s-
repressive modifications after Prmt5 knockdown using the
available antibody that primarily recognizes H4R3me2s
modification, but that also cross-reacts with methylated
histone H2A (Ancelin et al. 2006; Shechter et al. 2009).
Interestingly, when we examined histones from ES cells
depleted of Prmt5 using acid extraction, there was no sig-
nificant loss of H4R3me2s modification, but we observed
a dramatic and selective loss of H2AR3me2s modification
(Fig. 4B). Given that Prmt5 is predominantly cytoplasmic
and is not associated directly with the chromatin in ES cells
(Supplemental Fig. 2), this observation hints at a possibility
that predeposited histone H2A might be a key substrate of
Prmt5 in ES cells in vivo.
To pursue this observation further, we examined the
nuclear fraction of ES cells, and, as expected, arginine
methylation of both histone H2A and H4 was detected. In
contrast, in the cytoplasmic fraction, we found
that only H2A was predominantly methylated
(Fig. 4B), which further supports the idea that
Prmt5 might be important for the selective meth-
ylation of cytoplasmic predeposited H2A as one of
its key targets. We obtained additional evidence in
Prmt5 knockdown ES cells examined for up to 5 d,
which showed rapid loss of H2AR3me2s in the
cytosolic fraction at day 3, coincidentally with the
down-regulation of Prmt5, while the nuclear
H2AR3me2s levels changed in a more protracted
fashion by 5 d (Fig. 4C). The kinetics of the loss of
H2ARme2s in Prmt5-depleted ES cells—first in the
cytoplasm and then nuclear—lends credence to
the idea that Prmt5might methylate predeposited
H2A histones prior to their incorporation into the
chromatin.
To independently assess if methylated H2A
histones are involved in the repression of some
differentiation genes, we overexpressed methyla-
tion-deficient mutant H2A (H2AR3A) histones in
ES cells, which were readily incorporated into
chromatin (Supplemental Fig. 3) and resulted in
a significant up-regulation of several of the differ-
entiation genes (Fig. 4D). Many of these genes
were the same as those that were up-regulated
following the loss of Prmt5 in ES cells. Although
some genes were not affected, this might be be-
cause of differences in the extent to which H2AR3A
are incorporated into various promoters. Notably,
expression of pluripotency genes was unaffected
by H2AR3A, which rules out nonspecific effects
of H2AR3A overexpression in ES cells and points
to one particular role of Prmt5 in repression of
differentiation genes through methylation of his-
tone H2A, among others. Importantly, introduc-
tion of methylation-deficient mutant histones H4
(H4R3A) had no effect (Fig. 4D), which is consistent
with a lack of effect on H4 methylation following Prmt5
knockdown. These observations support the role of Prmt5-
mediated arginine methylation in the maintenance of
pluripotent ES cells by repression of differentiation-spe-
cific genes, in part through methylation of histone H2A.
The role of Mep50–Prmt5 in methylation
of predeposited H2A in ES cells
To obtain further support for our observations on meth-
ylation of predeposited H2A, we examined Mep50 (also
called Wdr77), a WD repeat-containing protein that we
detected as an interactor of Prmt5 in ES cells (Supplemen-
tal Fig. 4A). Mep50 is a key enzymatic cofactor of Prmt5
(Meister et al. 2001; Friesen et al. 2002) and specifically
directs Prmt5 toward nonnucleosomal histone H2A but
not H4 (Furuno et al. 2006). Notably,Mep50 is significantly
down-regulated during differentiation of ES cells, together
with H2AR3me2s modification (Fig. 5A), consistent with
a likely role of Prmt5/Mep50-mediated H2AR3me2s meth-
ylation in maintaining ES cell pluripotency. Importantly,
Mep50, like Prmt5, is predominantly cytoplasmic in ES
cells, and, furthermore, we confirmed Mep50–Prmt5 inter-
action by coimmunoprecipitation. Moreover, immunoflu-
orescence studies clearly showed colocalization of Prmt5
and Mep50 in the cytoplasm (Fig. 5B).
We checked the response of ES cells following Mep50
knockdown, and found that this resulted in the selective
Figure 3. Prmt5 is required for ES cell pluripotency. (A) Western blots depicting
efficiencies of Prmt5 shRNA knockdown constructs (KD 1-4) compared with
control (pSuper Control). Note phenotypic changes, diminution of Oct4 and
Nanog, and alkaline phosphatase staining in Prmt5-depleted cells 5 d after
knockdown. Tubulin was used as loading control. Bar, 30 mm. (B) qPCR analysis
of gene expression in Prmt5 knockdown cells harvested 5 d after knockdown.
Levels of transcripts were normalized relative to control shRNA transfection.
Error bars indicate standard deviations of three technical replicates. (C) Micro-
array heat map depicting expression changes of selected ES-associated genes as
well as developmental genes after Prmt5 knockdown (P < 0.01). Biological
triplicates were used. (PKD) Prmt5 knockdown; (CTRL) control knockdown.
Tee et al.
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loss of H2AR3me2s signal (Fig. 5C). This observation
reinforced the role of Prmt5/Mep50 in the methylation of
predeposited H2A. Importantly, loss of Mep50 also in-
duced ES cell differentiation (Fig. 5C), resulting in an up-
regulation of differentiation genes, as we observed fol-
lowing Prmt5 knockdown and H2AR3A overexpression
(Fig. 5D). However, as with H2AR3A overexpression,
pluripotency genes were less affected upon loss of Mep50
(Fig. 5D). This is in contrast to the pronounced down-
regulation of pluripotency genes in response to Prmt5
knockdown. These observations led us to conclude that,
whereas Prmt5/Mep50-mediated H2A methylation may
play an instructive role in ensuring repression of differen-
tiation genes, Prmt5 itself has additional independent roles
in maintaining ES cell pluripotency.
Prmt5-mediated repression of ES cell differentiation
may involve Stat3
Thus far, we focused on one aspect of Prmt5 function in
ES cells on the Mep50-mediated methylation of prede-
posited H2A histones that may contribute to the re-
pression of differentiation genes. However, Prmt5 can
also methylate nonhistone substrates, which may also
regulate pluripotency. We set off to identify the interactors
of cytoplasmic Prmt5 in an objective manner by perform-
ing mass spectrometry on the Prmt5 immunocomplexes
using ES cells stably expressing Prmt5-Flag (Supplemental
Fig. 4A). Mass spectrometry analysis identified both the
known and novel interactors of Prmt5, including Mep50
(as described previously) and Gemin5 (Gubitz et al. 2002).
Notably, we also detected Stat3, a key pluripotency tran-
scription factor downstream from the LIF signaling path-
way (Supplemental Fig. 4A).
LIF/Stat3 signaling plays a key role in the derivation
and maintenance of pluripotent ES cells through tran-
scriptional regulation (Niwa et al. 1998; Takeda et al.
1997; Matsuda et al. 1999). Furthermore, Stat3 can bind
to both pluripotency and differentiation genes in ES cells,
suggesting that it has a role in both gene activation and
repression (Kidder et al. 2008). To determine if Prmt5
might act in conjunction with Stat3, we first examined
the expression of Stat3, and noted some similarities with
Prmt5 in the early embryos. Like Prmt5, Stat3 is tran-
siently down-regulated in the epiblast of E4.5 blastocysts,
followed by up-regulation in the ICM outgrowth during
ES cell derivation (Supplemental Fig. 4B). Additionally,
like the Prmt5-null embryos, Stat3 loss of function is
early embryonic-lethal (Takeda et al. 1997).
We confirmed Prmt5–Stat3 interaction by coimmuno-
precipitation in ES cells, and also found that the activated
Figure 4. Prmt5 methylates predeposited histone H2A. (A) In vitro
methyltransferase assay using Flag-Prmt5 immunoprecipitated from
ES cells and incubated with histone substrates (recombinant H2A,
rH2A, or calf thymus histone preparations) and radioactive 3H-SAM.
Fluorograph (FG) and Coomassie (CM) blots are shown. (B) Western
blot showing loss of H2AR3me2s in Prmt5-depleted cells. (Left
panel) Histones were isolated using acid extraction at day 5 of
knockdown. ES cell fractions show H2AR3me2s/H4R3me2s in
nuclear fraction but only H2AR3me2s in the cytoplasm (long
Western blot exposure was performed). Purity of the preparations
was confirmed by TBP (TATA-binding protein) (nuclear) and Tubulin
(cytoplasmic) expression. (Right panel) H4R3me2a (asymmetric H4
dimethylation). (C) Time-course experiment showing loss of cyto-
solic H2AR3me2s upon depletion of Prmt5 in ES cells between 0 and
5 d. H4K5 acetylation (H4K5Ac) was used as a marker for cytosolic
H4 and also served as loading control. Cytosolic H2AR3me2s was
down-regulated first on day 3 (d3), concomitantly with the loss of
Prmt5. Nuclear H2AR3me2s was subsequently down-regulated on
day 5 (d5). (D) qPCR analysis of gene expression changes upon
overexpression of methylation-deficient H2A and H4 histones.
Mutant histones (containing IRES-GFP) were transfected into ES
cells, and both ‘‘GFP+’’ and ‘‘GFP’’ (control) cells were isolated by
FACS and subjected to qPCR. Error bars represent the standard
deviations of three technical replicates.
Figure 5. Prmt5/Mep50-mediated H2AR3me2s is important for
pluripotency. (A) Down-regulation of Mep50 during differentiation
of ES cells. Loss of Mep50 at day 4 (d4) of differentiation was
accompanied by a specific decrease in H2AR3me2s. (B) Prmt5 and
Mep50 interact in ES cells. Immunoprecipitations using ES cells
either transiently transfected with Flag-Prmt5 or stably expressing
Prmt5-Flag (clone 9) and blotted for endogenous Mep50. Immuno-
stainings showing colocalization of Mep50 with Flag-Prmt5 in the
cytoplasm of ES cells. Transfected cells are denoted by GFP staining.
Nuclei were counterstained with DAPI (blue). Bar, 20 mm. (C)Mep50
knockdown (5 d) leads to loss of H2AR3me2s and results in ES cell
differentiation. Bar, 30 mm. (D) qPCR analysis of gene expression
upon Mep50 knockdown (5 d) in ES cells. Levels of transcripts were
normalized with respect to control shRNA transfection. Error bars
indicate standard deviations of three technical replicates.
Cytoplasmic Prmt5 and ES cell pluripotency
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form of Stat3 (phosphorylated on Y705; pStat3[Y705])
exists in the Prmt5 immunocomplex, which is also
supported by their coelution in gel filtration. However,
phosphorylation of Y705 on Stat3 is not obligatory for the
Stat3–Prmt5 interaction (Supplemental Fig. 4C). In vitro
methylation assay also revealed no detectable methyla-
tion of Stat3, suggesting that it is not a substrate of Prmt5,
at least in vitro (Supplemental Fig. 4D; data not shown).
Furthermore, activation of the LIF/Stat3 pathway itself
was not perturbed in Prmt5-depleted ES cells, since
expression of Stat3-activated targets, such as Socs3 and
Stat3 itself, was not significantly affected (Fig. 3A), and the
levels of pStat3(Y705) were similar in both the Prmt5
knockdown and control ES cells (Supplemental Fig. 4E).
Therefore, Prmt5 does not appear to regulate Stat3-de-
pendent gene activation. In contrast, depletion of Prmt5 in
ES cells caused up-regulation of differentiation genes,
including Fgf5, Gata6, Lhx1, and FoxA2, and several Hox
genes such as HoxA3, HoxA7, and HoxD9 (Fig. 3B,C).
Notably, all of these are known direct repressed targets of
Stat3 (Kidder et al. 2008), which suggests that the effect of
loss of Prmt5might be predominantly on the Stat3-bound
repressed targets.
Although our observations suggest that Prmt5–Stat3
association might function to selectively repress differ-
entiation genes in ES cells, how this occurs in conjunc-
tion with the methylation of predeposited H2A remains
to be elucidated. However, we note an interaction be-
tween Stat3 and Nap1 (Supplemental Fig. 5), a histone
chaperone for H2A–H2B dimers (Mosammaparast et al.
2002), which might provide a possible route for the
incorporation of H2AR3me2s into the chromatin. Nota-
bly, a mechanism for signal-based targeted deposition of
histones was demonstrated previously for histones H3–
H4, which involves chaperone Asf1 in conjunction with
the DNA-binding factor Su(H), for the repression of Notch
target genes (Goodfellow et al. 2007). Indeed, more re-
cently, distinct DNA-binding factors were found to be
responsible for targeted deposition of histone variant H3.3
in ES cells on both active and repressed genes in a DNA
replication-independent manner (Goldberg et al. 2010).
It is therefore conceivable that deposition of repres-
sive H2AR3me2s in the genome may occur by a similar
mechanism. The presence of pre-existing methylated H2A
may serve to potentiate other downstream histone mod-
ifications (Loyola et al. 2006), and its introduction into
chromatin may directly alter the pre-existing chromatin
templates at particular genomic loci.
Concluding remarks
This study demonstrates a role of Prmt5 function in early
mouse development and pluripotency. The nuclear–cyto-
plasmic translocations of Prmt5 during preimplantation
development, PGC specification, and EG and ES deriva-
tion coincide with significant developmental transitions
and cell fate decisions. We recently generated a condi-
tional allele for Prmt5 to further examine the role of
maternal inheritance of Prmt5 in preimplantation em-
bryos and during various stages of development. Notably,
the transient loss of Prmt5 in the ICM apparently occurs
by post-transcriptional regulation, and may reflect a gen-
eral mechanism to evoke rapid cell fate decisions. The
subsequent up-regulation and cytoplasmic localization of
Prmt5 in the emerging ES cells is coupled with the up-
regulation of Stat3. One purpose of these factors is to
repress differentiation. In contrast, up-regulation of cyto-
plasmic Prmt5 in the post-implantation epiblast cells in
vivo occurs without the concomitant up-regulation of
Stat3, presumably to allow these embryonic epiblast cells
to commence differentiation (Supplemental Fig. 6). No-
tably, reprogramming of unipotent PGCs to pluripotent
EG cells, which also requires LIF/Stat3 signaling, results
in the translocation of Prmt5 from the nucleus to the
cytoplasm (Durcova-Hills et al. 2008). Given the recent
demonstration that Stat3 activation contributes directly to
induction of pluripotency (Yang et al. 2010), the functional
association of Prmt5 and Stat3 may provide further in-
sights into the molecular mechanism underlying epige-
netic reprogramming toward pluripotency.
In ES cells, Prmt5 acts through Mep50 to mediate
methylation of predeposited H2A histones, which con-
tributes to the repression of several differentiation genes,
some of which are apparently Stat3 targets. Prmt5 may
have additional roles, independent of H2A methylation,
in regulating pluripotency, since the response of ES cells
to the loss of Mep50 (and H2AR3A overexpression) is more
specific compared with the more pronounced effect of
loss of Prmt5. Indeed, other putative substrates of Prmt5
may also be involved in maintaining ES cell pluripotency;
these may include either nonhistones or perhaps other
H2A variants. Interestingly, Prmt5 has the potential to
methylate all H2A variants, with the exception of H2A.Z,
which lacks an Arg 3 residue in the N-terminal tail and
therefore is refractory to methylation (Supplemental
Fig. 7). As such, an interchange between H2A.Z and
H2AR3me2s depositions could be important for transcrip-
tional regulation in ES cells. The abundance of predepos-
ited methylated H2A histones in ES cells is reminiscent of
that reported in Xenopus oocytes (Shechter et al. 2009).
This may be one general property of the totipotent and
pluripotent uncommitted states to ensure developmental
plasticity.
The cytoplasmic localization of Prmt5 provides a
unique experimental system to investigate how epige-
netic regulation may be coupled to signal transduction
prior to changes in the chromatin template. The reported
evidence for cytosolic Ezh2 complex may similarly link
additional signal transduction pathways (Su et al. 2005).
Our work suggests that Prmt5 may cooperate with the
LIF/Stat3 pathway to repress differentiation, and such
coupling of signal-induced epigenetic response can pro-
vide a mechanism to promote andmaintain pluripotency,
while preserving the ability to alter the epigenome
rapidly upon exposure to differentiation cues.
Materials and methods
Analysis of Prmt5 mutants and knockdown in ES cells
Prmt5+/ gene trap ES cells were obtained from BayGenomics (clone
RRA014) and injected into C57BL/6 blastocysts to generate chimeric
mice. Isolation, stainings, and in vitro culture of blastocysts was per-
formed as described previously (Maldonado-Saldivia et al. 2007). Whole-
mount immunostainings on E6.5 embryos were carried out as described
(Ohinata et al. 2005). shRNA oligonucleotides were cloned into pSuper-
puro (Oligoengine).
Gene expression analysis and cell fractionation
Microarray gene expression profiling was performed using the Illumina
microarray platform (mouseWG6 expression BeadChip). Cell fractionation
was carried out as described previously, with minor modifications
Tee et al.
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(Nimura et al. 2006; Groth et al. 2007). Full experimental details are
provided in the Supplemental Material.
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